These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16130277)

  • 21. Rejection and acceptance of corneal allografts.
    Klebe S; Coster DJ; Williams KA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.
    Tavandzi U; Procházka R; Usvald D; Hlucílová J; Vitásková M; Motlík J; Vítová A; Filipec M; Forrester JV; Holán V
    Transplantation; 2007 May; 83(10):1401-3. PubMed ID: 17519795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of corneal graft rejection by passive cell transfer.
    Khodadoust AA; Silverstein AM
    Invest Ophthalmol; 1976 Feb; 15(2):89-95. PubMed ID: 1357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term results of FK 506 eye drops following corneal transplantation].
    Reis A; Mayweg S; Birnbaum F; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):57-61. PubMed ID: 18236371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latanoprost does not affect immune privilege of corneal allografts.
    Wang M; Kitahara Y; Yoshida A; Hori J
    Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunobiology of corneal transplantation.
    Williams KA; Coster DJ
    Transplantation; 2007 Oct; 84(7):806-13. PubMed ID: 17984831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results].
    Goichot-Bonnat L; Chemla P; Pouliquen Y
    J Fr Ophtalmol; 1987; 10(3):213-7. PubMed ID: 3301994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilocarpine-associated allograft rejection in postkeratoplasty patients.
    Massry GG; Assil KK
    Cornea; 1995 Mar; 14(2):202-5. PubMed ID: 7743805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of minor histocompatibility antigens in solid organ transplantation.
    Dierselhuis M; Goulmy E
    Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppression in corneal transplantation].
    Scheer S; Touzeau O; Borderie V; Laroche L
    J Fr Ophtalmol; 2003 Jun; 26(6):637-47. PubMed ID: 12910207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrospective evaluation of risk factors for graft rejection in patients after corneal transplantation performed at the Eye Clinic in the years 2001-2003].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Cieślik K
    Klin Oczna; 2005; 107(4-6):209-11. PubMed ID: 16118919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.
    Tabbara KF
    Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major endothelial loss from corneas in organ culture: importance of second endothelial count.
    Builles N; Kodjikian L; Burillon C; Damour O
    Cornea; 2006 Aug; 25(7):815-20. PubMed ID: 17068459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and risk factors for corneal graft rejection.
    Sellami D; Abid S; Bouaouaja G; Ben Amor S; Kammoun B; Masmoudi M; Dabbeche K; Boumoud H; Ben Zina Z; Feki J
    Transplant Proc; 2007 Oct; 39(8):2609-11. PubMed ID: 17954190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.
    Hunter PA; Wilhelmus KR; Rice NS; Jones BR
    Clin Exp Immunol; 1981 Jul; 45(1):173-7. PubMed ID: 7030537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of corneal transplantation.
    Ziaei M; Sharif-Paghaleh E; Manzouri B
    Expert Opin Pharmacother; 2012 Apr; 13(6):829-40. PubMed ID: 22424532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.